Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- SFA ISRIndependent statistical analysis of Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SGI-110Independent statistical analysis of SGI-110 in Combination With Carboplatin in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01696032).
- SH-DS01 on Fecal Metagenomic Stability: Complete Statistical AnalysisIndependent statistical analysis of SH-DS01 on Fecal Metagenomic Stability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04598295).
- Shared Decision Making About Medication Use for People With Multiple Health Problems: Complete Statistical AnalysisIndependent statistical analysis of Shared Decision Making About Medication Use for People With Multiple Health Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: Complete Statistical AnalysisIndependent statistical analysis of Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337203).
- SHAREDCareIndependent statistical analysis of Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SHARPENIndependent statistical analysis of SHARPEN - Parkinson's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05987540).
- SHARPSIndependent statistical analysis of Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHIELDIndependent statistical analysis of 38 Week Extension Study to CAIN457C2303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01093846).
- Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: Complete Statistical AnalysisIndependent statistical analysis of Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06250738).
- Shifting Salty Taste Preferences in Children: Complete Statistical AnalysisIndependent statistical analysis of Shifting Salty Taste Preferences in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02909764).
- SHINEIndependent statistical analysis of A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: Complete Statistical AnalysisIndependent statistical analysis of SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: Complete Statistical AnalysisIndependent statistical analysis of ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03328949).
- Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02650128).
- Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: Complete Statistical AnalysisIndependent statistical analysis of Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections: Complete Statistical AnalysisIndependent statistical analysis of Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466817).
- Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03141905).
- Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives: Complete Statistical AnalysisIndependent statistical analysis of Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00775190).
- SIGNATUREIndependent statistical analysis of LDE225 for Patients With PTCH1 or SMO Mutated Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002689).
- Sildenafil Treatment for Mild TBI: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Treatment for Mild TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598140).
- SILDI-SAFEIndependent statistical analysis of Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04447989).
- Silk’n HST Device Usability and Self Selection Study: Complete Statistical AnalysisIndependent statistical analysis of Silk'n HST Device Usability and Self Selection Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919007).
- Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04191421).
- Silver Diamine Fluoride and Papain-Based Gel for Management of MIH-affected Molar in Paediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Silver Diamine Fluoride and Papain-Based Gel for Management of MIH-affected Molar in Paediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SIMAPIndependent statistical analysis of Pictograms to Facilitate Comprehension of Medical Indications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05609760).
- Simplified Insulin Regimen for the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Simplified Insulin Regimen for the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03660553).
- Simplifying Treatment and Monitoring for HIV (STREAM HIV): Complete Statistical AnalysisIndependent statistical analysis of Simplifying Treatment and Monitoring for HIV (STREAM HIV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04341779).
- Simultaneous Assessment of FFR and SPECT: Complete Statistical AnalysisIndependent statistical analysis of Simultaneous Assessment of FFR and SPECT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02749045).
- Simultaneous mRNA COVID-19 and IIV4 Vaccination Study: Complete Statistical AnalysisIndependent statistical analysis of Simultaneous mRNA COVID-19 and IIV4 Vaccination Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05028361).
- Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00919035).
- Single Ascending Dose Study of AMG 570 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Ascending Dose Study of AMG 570 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02618967).
- Single Dose CHG Pharmacokinetic Study: Complete Statistical AnalysisIndependent statistical analysis of Single Dose CHG Pharmacokinetic Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03331263).
- Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611): Complete Statistical AnalysisIndependent statistical analysis of Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Complete Statistical AnalysisIndependent statistical analysis of Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: primary endpoint results, effect estimate with confidence interval, sample-size…
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): Complete Statistical AnalysisIndependent statistical analysis of Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01106287).
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Single or Double-layer Uterine Closure Techniques: Complete Statistical AnalysisIndependent statistical analysis of Single or Double-layer Uterine Closure Techniques: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03629028).
- Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SIPIIndependent statistical analysis of Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- sipITIndependent statistical analysis of Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SirolimusIndependent statistical analysis of Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sirolimus for Autoimmune Disease of Blood Cells: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus for Autoimmune Disease of Blood Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00392951).
- Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02357342).